{"id":"https://openalex.org/W1998296476","doi":"https://doi.org/10.1046/j.1365-2141.1998.00751.x","title":"Differential activity of P\u2010glycoprotein in normal blood lymphocyte subsets","display_name":"Differential activity of P\u2010glycoprotein in normal blood lymphocyte subsets","alternate_titles":[],"publication_year":1998,"publication_date":"1998-06-01","ids":{"openalex":"https://openalex.org/W1998296476","doi":"https://doi.org/10.1046/j.1365-2141.1998.00751.x","mag":"1998296476","pmid":"https://pubmed.ncbi.nlm.nih.gov/9674746"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2141.1998.00751.x","doi":"https://doi.org/10.1046/j.1365-2141.1998.00751.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2141.1998.00751.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1998296476"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109191221","display_name":"Christof Ludescher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190249584","display_name":"Universit\u00e4t Innsbruck","ror":"https://ror.org/054pv6659","country_code":"AT","type":"education","lineage":["https://openalex.org/I190249584"]}],"countries":["AT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Christof Ludescher","raw_affiliation_strings":["Department of Internal Medicine, University of Innsbruck, Austria","Department of Internal Medicine, Division of Haematology and Oncology,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, University of Innsbruck, Austria","institution_ids":["https://openalex.org/I190249584"]},{"raw_affiliation_string":"Department of Internal Medicine, Division of Haematology and Oncology,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078876581","display_name":"Georg Pall","orcid":"https://orcid.org/0000-0003-1899-5221","observed_orcids":["https://orcid.org/0000-0003-1899-5221"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Georg Pall","raw_affiliation_strings":["Department of Internal Medicine, Division of Haematology and Oncology,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Haematology and Oncology,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111568041","display_name":"Eveline U. Irschick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190249584","display_name":"Universit\u00e4t Innsbruck","ror":"https://ror.org/054pv6659","country_code":"AT","type":"education","lineage":["https://openalex.org/I190249584"]}],"countries":["AT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eveline U. Irschick","raw_affiliation_strings":["Department of Ophthalmology, Immunological Laboratory, University of Innsbruck, Innsbruck, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Immunological Laboratory, University of Innsbruck, Innsbruck, Austria","institution_ids":["https://openalex.org/I190249584"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109346630","display_name":"G\u00fcnther A. Gastl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G\u00fcnther Gastl","raw_affiliation_strings":["Department of Internal Medicine, Division of Haematology and Oncology,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Haematology and Oncology,","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109191221"],"corresponding_institution_ids":["https://openalex.org/I190249584"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":1.0425,"has_fulltext":false,"cited_by_count":75,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.76667107,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"101","issue":"4","first_page":"722","last_page":"727"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.996999979019165},{"id":"https://openalex.org/keywords/mdr1","display_name":"MDR1","score":0.6140000224113464},{"id":"https://openalex.org/keywords/lymphocyte-subsets","display_name":"lymphocyte subsets","score":0.8119999766349792},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.8339999914169312},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.9549999833106995},{"id":"https://openalex.org/keywords/naive-t-cells","display_name":"naive T cells","score":0.8199999928474426},{"id":"https://openalex.org/keywords/memory-t-cells","display_name":"memory T cells","score":0.9959999918937683},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8450000286102295},{"id":"https://openalex.org/keywords/rhodamine-123-efflux","display_name":"rhodamine 123 efflux","score":0.9800000190734863},{"id":"https://openalex.org/keywords/cd45ra","display_name":"CD45RA","score":0.6899999976158142},{"id":"https://openalex.org/keywords/cd11b","display_name":"CD11b","score":0.890999972820282},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.6320000290870667},{"id":"https://openalex.org/keywords/nk-cell-cytotoxicity","display_name":"NK cell cytotoxicity","score":0.7870000004768372},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.9440000057220459},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6759999990463257},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.8759999871253967}],"concepts":[{"id":"https://openalex.org/C2778589691","wikidata":"https://www.wikidata.org/wiki/Q3429577","display_name":"Rhodamine 123","level":4,"score":0.6885095238685608},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.673855185508728},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.6381101608276367},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.6220699548721313},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.6065992712974548},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5830468535423279},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.577730119228363},{"id":"https://openalex.org/C2992881475","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T lymphocyte","level":3,"score":0.504972517490387},{"id":"https://openalex.org/C129374314","wikidata":"https://www.wikidata.org/wiki/Q909381","display_name":"Interleukin 21","level":4,"score":0.4834824204444885},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4809257686138153},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.4733215272426605},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4603860378265381},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.4495302140712738},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2519914507865906},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.19207096099853516},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16829752922058105},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.056753009557724},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D005456","descriptor_name":"Fluorescent Dyes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012235","descriptor_name":"Rhodamines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016176","descriptor_name":"T-Lymphocyte Subsets","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018432","descriptor_name":"Drug Resistance, Multiple","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020112","descriptor_name":"Rhodamine 123","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1365-2141.1998.00751.x","doi":"https://doi.org/10.1046/j.1365-2141.1998.00751.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2141.1998.00751.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:9674746","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9674746","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W25713858","https://openalex.org/W47219713","https://openalex.org/W117604019","https://openalex.org/W205982489","https://openalex.org/W220750778","https://openalex.org/W1526872663","https://openalex.org/W1723032639","https://openalex.org/W1967019771","https://openalex.org/W2005362904","https://openalex.org/W2008260112","https://openalex.org/W2009098269","https://openalex.org/W2013540958","https://openalex.org/W2027947014","https://openalex.org/W2044676165","https://openalex.org/W2044849811","https://openalex.org/W2045028737","https://openalex.org/W2063230624","https://openalex.org/W2081266951","https://openalex.org/W2087774304","https://openalex.org/W2088759826","https://openalex.org/W2121528021","https://openalex.org/W2122355443","https://openalex.org/W2125760667","https://openalex.org/W2138993111","https://openalex.org/W2144775951","https://openalex.org/W2155782151","https://openalex.org/W2181131337","https://openalex.org/W2227630971","https://openalex.org/W2280630460","https://openalex.org/W2314331148","https://openalex.org/W2408271097","https://openalex.org/W2615953705"],"related_works":["https://openalex.org/W2027947014","https://openalex.org/W2121908223","https://openalex.org/W778466901","https://openalex.org/W4405897431","https://openalex.org/W2044849811","https://openalex.org/W2112930277","https://openalex.org/W1986587610","https://openalex.org/W2408616152","https://openalex.org/W2012893802"],"abstract_inverted_index":{"To":[0],"better":[1],"understand":[2],"the":[3,27,94,102,131,136,147,161,185,191,209],"phenomenon":[4],"of":[5,134,151,163,174,193,199,204,211],"P-glycoprotein":[6],"(P-170)":[7],"expression":[8,173],"we":[9],"investigated":[10],"lymphocyte":[11,206],"subpopulations":[12,98],"for":[13],"P-170":[14,56,73,79,152,175,200],"function":[15,80],"in":[16,43,84,93,146,160,167,177,190,201],"healthy":[17],"volunteers.":[18],"Studies":[19],"were":[20],"based":[21],"on":[22],"three-colour":[23],"flow":[24],"cytometry":[25],"including":[26],"fluorescent":[28],"probe":[29],"rhodamine":[30],"123":[31],"(Rh123),":[32],"which":[33],"is":[34],"transported":[35],"by":[36],"P-170.":[37],"Marked":[38],"Rh123":[39,89],"efflux":[40,90,106],"was":[41,81,91,144,157],"detected":[42],"CD8+":[44,103,113],"T":[45,49,67,86,122,181],"lymphocytes":[46],"with":[47,60,184],"CD8+/CD45RA+":[48],"cells":[50,62,68,77,128,143,182],"(naive":[51],"cells)":[52,70],"showing":[53],"significantly":[54,108,158],"higher":[55,92],"activity":[57,74,176],"as":[58,116,118,217],"compared":[59],"CD8+/CD45RA-":[61],"(P<0.04).":[63,78],"Vice":[64],"versa,":[65],"CD8+/CD45RO+":[66],"(memory":[69],"demonstrated":[71],"less":[72,82],"than":[75],"CD8+/CD45RO-":[76],"prominent":[83],"CD4+":[85,115],"cells,":[87],"however,":[88],"CD4+/CD45RA+":[95],"and":[96,111,114,120,165,179],"CD4+/CD45RO-":[97],"(P<0.025)":[99],"corresponding":[100],"to":[101,214,220],"results.":[104],"Dye":[105],"differed":[107],"between":[109],"activated":[110],"non-activated":[112],"well":[117],"CD8+/CD11b+":[119],"CD8+/CD11b-":[121],"lymphocytes.":[123],"Since":[124],"CD16+":[125],"natural":[126],"killer":[127],"(NK)":[129],"expressed":[130],"highest":[132],"level":[133],"P-170,":[135],"NK":[137,154,187],"cytotoxicity":[138,156,189],"against":[139],"51Cr-labelled":[140],"K562":[141],"target":[142],"assayed":[145],"presence":[148,162,192],"or":[149],"absence":[150],"inhibitors.":[153],"related":[155,188],"reduced":[159,186],"R-verapamil":[164],"dexnigaldipine-HCP":[166],"a":[168,196,218],"dose-dependent":[169],"manner.":[170],"The":[171],"differential":[172],"naive":[178],"memory":[180],"together":[183],"MDR-modulators":[194],"suggest":[195],"physiological":[197],"role":[198],"immunological":[202],"functions":[203],"these":[205],"subsets.":[207],"Consequently,":[208],"addition":[210],"MDR":[212],"modulators":[213],"conventional":[215],"chemotherapy":[216],"strategy":[219],"overcome":[221],"drug":[222],"resistance":[223],"should":[224],"consider":[225],"possible":[226],"adverse":[227],"immunosuppressive":[228],"effects.":[229]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1998296476","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
